Amarin (AMRN) NCE Delay Could Be Related to Patents
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/1/2026
- Wall Street ends higher as Amazon soothes AI jitters
- Amazon shares rally as cloud growth surges and spending outlook climbs
- Apple shares sink on disappointing September quarter sales outlook
- Novo Nordisk stock tumbles 10% as key trial misses goal
- AI wizkid Leopold Aschenbrenner forced to sell entire portfolio after rout
- SCYNEXIS (SCYX) Move Attributed to Morning Note from Brookline
- AbbVie (ABBV) Misses Q2 EPS by 6c, Beats on Revenue; Offers FY26 EPS Guidance
- Novo Nordisk's ziltivekimab fails to reduce heart risk in ZEUS trial
- Wall Street ends higher as Amazon soothes AI jitters
- Short sellers pile into SpaceX ahead of earnings, lockup expiration
- After-Hours Stock Movers: AAPL, AMZN, COIN, RBLX, RDDT, AXTI, FND, WU, GDDY
- After-Hours Stock Movers: META, MSFT, CMG, SBUX, CVNA, LRCX, FTNT, QCOM, TDOC
- After-Hours Stock Movers: F, BE, STX, WDC, KLAC, SWKS, NXPI, CSGP, ENPH
- After-Hours Stock Movers: FFIV, CDNS, APLD, RMBS, ESI, SANM
- After-Hours Stock Movers: INTC, AMD, ARM, MXL, EW, DECK
Canaccord Genuity Reiterates a 'Buy' on Amarin Corporation (AMRN); Positive View on Vascepa
September 11, 2012 8:18 AM EDTCanaccord Genuity reiterates a 'Buy' on Amarin Corporation (NASDAQ: AMRN) price target of $26.00.
Analyst, Ritu Baral, said, "Reiterate rating and price target; maintain positive view on Vascepa approval and commercial, partnering potential. We continue to expect BD talks to intensify and Vascepa to... More
Amarin Corp (AMRN) Pressured Early as Vascepa Orange Book Decision Delayed...Again
September 11, 2012 8:15 AM EDTShares of Amarin Corp Plc (Nasdaq: AMRN) are getting hit Tuesday morning following a late-Monday disclosure for Vascepa.
According to the filing, Amarin... More
Amarin (AMRN) Said No FDA NCE Decision in August Orange Book
September 10, 2012 5:10 PM EDTAmarin Corp Plc (NASDAQ: AMRN) said after the close of trading Monday that it does not expect an FDA NCE decision by the next Orange Book, due on our about September 14, 2012.
From the filing:
Typically, the U.S. Food and Drug Administration (FDA) publishes a determination on the... More
